1-4 of 4
Khaled M. Ramadan, MBBCh, MRCPI, FRCPath, FRCP, FRCPC
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada

Lauren J. Lee, MD, Alina S. Gerrie, MD FRCPC, Helene Bruyere, MD FCCMG, Tanya L. Gillan, PhD FCCMG, Stephen J.T. Huang, BMLSc, Cynthia L. Toze, MD FRCPC, Khaled M. Ramadan, MBBCh, MRCPI, FRCPath, FRCP, FRCPC
Journal: Blood
Blood (2014) 124 (21): 3344.
https://doi.org/10.1182/blood.V124.21.3344.3344
Published: 2014
Journal Articles

Clonal Evolution Predicts Poor Prognosis in Chronic Lymphocytic Leukaemia and Is Possibly a Worse Prognostic Factor Than 17p Deletion: A Population Based Cohort study of FISH Testing in British Columbia, Canada

Krystal Bergin, MBBS, Alina S. Gerrie, MD, FRCPC, Steven J.T. Huang, BMLSc, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Aly Karsan, MD, Monica Anne Hrynchak, MD, FRCP(C), Chinmay B. Dalal, MD, Helene Bruyere, MD, FCCMG, Adam C. Smith, PhD, FCCMG, FACMG, Cynthia L. Toze, MD, MHSc, FRCPC, Tanya L. Gillan, PhD, FCCMG
Journal: Blood
Blood (2012) 120 (21): 1401.
https://doi.org/10.1182/blood.V120.21.1401.1401
Published: 2012
Journal Articles

Comprehensive Assessment of Clinical Outcomes for CLL Patients with Trisomy 12 (+12): Results of a Population-Based Analysis of 822 CLL Patients in British Columbia (BC), Canada

Alina S. Gerrie, MD, FRCPC, MPH, Steven J.T. Huang, BMLSc, Helene Bruyere, MD, FCCMG, Chinmay B. Dalal, MD, Monica Anne Hrynchak, MD, FRCP(C), Aly Karsan, MD, Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Adam C. Smith, PhD, FCCMG, FACMG, Tanya L. Gillan, PhD, FCCMG, Cynthia L. Toze, MD, FRCP(C)
Journal: Blood
Blood (2012) 120 (21): 3897.
https://doi.org/10.1182/blood.V120.21.3897.3897
Published: 2012
Journal Articles

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis

Heather A Leitch, MD, PhD, FRCPC, Christopher Chan, Chantal S Leger, MD, FRCP(C), Lynda M Foltz, MD, FRCP(C), Khaled M Ramadan, MBBCH, MRCPI, FRCPath, FRCP, FRCPC, Linda M Vickars, MD, FRCP(C)
Journal: Blood
Blood (2011) 118 (21): 1732.
https://doi.org/10.1182/blood.V118.21.1732.1732
Published: 2011